Potassium-chloride cotransporter 1 (SLC12A4) (KCC1)

Potassium-chloride cotransporter 1 (KCC1), encoded by the SLC12A4 gene, is a member of the solute carrier family 12 that mediates the electroneutral symport of potassium and chloride ions across the plasma membrane (UniProt Q9UP95 [1]). In erythrocytes, KCC1 and its related isoform KCC3 are the primary pathways for K-Cl efflux, playing a vital role in maintaining cell volume and hydration (Mount et al., 2002 [2]). In sickle cell disease (SCD), these transporters are pathologically activated by factors such as cell swelling, acidification, and deoxygenation, leading to significant erythrocyte dehydration (Brugnara, 2003 [3]). This dehydration increases the intracellular concentration of sickle hemoglobin (HbS), which exponentially accelerates HbS polymerization and the subsequent sickling of red blood cells. Consequently, KCC1 is a therapeutic target; inhibiting its activity aims to preserve erythrocyte volume and reduce the clinical complications of SCD. While magnesium supplementation has been shown to reduce KCC activity and improve cell hydration in clinical trials (De Franceschi et al., 1997 [4]), the development of highly selective small-molecule inhibitors remains a challenge due to the risk of cross-inhibiting KCC2, which is essential for inhibitory neurotransmission in the central nervous system (Adragna et al., 2006 [5]).

Other names

SLC12A4KCC1Erythrocyte K-Cl cotransporterSolute carrier family 12 member 4K-Cl cotransporter 1

Inhibition of the electroneutral efflux of potassium and chloride ions to maintain erythrocyte hydration and prevent hemoglobin S polymerization [2, 3].